ColumbiaX: Fighting HIV with Antiretroviral Therapy: Implementing the Treat-All Approach

- Duration
- 6 weeks
- Price Value
- $ 49
- Difficulty Level
- Intermediate
Offered by ColumbiaX
This comprehensive course focuses on equipping healthcare professionals with the latest knowledge and skills in HIV treatment and prevention. The course is designed to align with the World Health Organization's 2016 updated consolidated guidelines on the use of antiretroviral drugs in combating HIV.
This intermediate-level course is designed for healthcare professionals, including doctors, nurses, pharmacists, and laboratory technicians, who are involved in HIV care and treatment. It is particularly beneficial for those looking to update their knowledge and skills in line with the latest WHO guidelines.
The skills acquired in this course will directly impact the quality of care provided to HIV patients. Healthcare professionals will be able to:
This self-directed course is taught by clinical experts in HIV and global health, allowing students to learn at their own pace and accommodate their individual schedules. By completing this course, healthcare professionals will be well-equipped to provide cutting-edge HIV care and contribute significantly to the global fight against the HIV epidemic.
Explore more courses to enhance your cloud computing and Kubernetes skills.
Why study Representations of HIV/AIDS? What is our course philosophy?
This class engages students in a transdisciplinary conversation about representations of HIV/AIDS: in scientific articles, journalism, visual art, literature, drama, and popular culture. You will join us in studying widely varying representations of HIV/AIDS from the perspective of the kinds of academics we are: a literary critic and a scientist. We believe that scientists and literary/cultural critics can learn valuable lessons from one another, even as they create their own responses to HIV/AIDS. Today, over 30 years since the first scientific reports of HIV/AIDS, the pandemic remains a major health concern throughout the world. But, rays of hope have led to speculation that an AIDS-free generation may be possible. In such a timely moment, it is essential for us to connect across the "two cultures" as we consider the social and scientific implications of HIV/AIDS.
Throughout this course from the Stanford Center for Health Education (SCHE), you’ll discover a range of pharmacological and nonpharmacological interventions for individuals at risk of heart disease. You’ll also learn how to improve patient engagement and outcomes.
Developed by leading researchers and clinicians from across Canada, this course will enhance knowledge and skills for clinicians who are using or beginning to use a biosimilar or biologic medicine in their professional practice setting.
Developed by leading researchers and clinicians from across Canada, this course will enhance knowledge and skills for patients who are using, or beginning to use, an originator or biosimilar biologic medicine.